Clinical Trials Logo
  1. Home
  2. Coronavirus Infection
  3. NCT04847817
  4. Details
NCT04847817 Clinical Trial

Important Data on COVID-19 Profile in Africa

Coronavirus Infection Clinical Trial

— AIDCO  

Official title:
Important Data on COVID-19 Profile in Africa

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04847817
Other study ID # 0011/2020/PR/SG/CNE
Secondary ID CEI-10/2020
Status Completed
Phase
First received
Last updated
Start date August 1, 2020
Est. completion date March 1, 2022

Study information
Verified date April 2021
Source Centre de Recherche Médicale de Lambaréné
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to Understand the natural history of Coronavirus 2019 (COVID-19) infection to better define the period of infectiousness and transmissibility and to establish biobanks of COVID-19 blood and mucosal samples.

Description:

In this study ,the participants will be enrolled sequentially in the COVID-19 care referral centers. The infected hospitalized patient will be identified by the physicians in hospital. After the patient has given his/her informed consent the permission will be sought from him to approach his household contacts. The household contacts will be screened, and included in the study. Patients hospitalized and positive for COVID-19 by PCR and their household contacts of all ages and gender (40% minimum of female), will be enrolled upon receipt of written informed consent.

Recruitment information / eligibility
Status Completed
Enrollment 574
Est. completion date March 1, 2022
Est. primary completion date December 31, 2021
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Molecular (PCR) confirmed COVID-19 patients hospitalized in referral centers, - Household contacts of hospitalized COVID-19 patient, - Provided signed informed consent. Exclusion Criteria: - Pregnancy

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Gabon Centre de Recherches Médicales de Lambréné Lambaréne
Gabon Centre de Recherches Médicales de Lammbaréné Lambaréné Moyen- Ogooué

Sponsors (7)
Lead Sponsor Collaborator
Centre de Recherche Médicale de Lambaréné Armauer Hansen Research Institute, Ethiopia, European and Developing Countries Clinical Trials Partnership (EDCTP), Institut de recherche en santé de surveillance épidémiologique et de formation, Leiden University Medical Center, Universität Tübingen, Université des Sciences de la Santé

Country where clinical trial is conducted

Gabon, 

Outcome
Type Measure Description Time frame Safety issue
Primary clinical and biological parameters of COVID-19 Infection and disease progression - Pattern of virus transmission 14 days
Primary SARS-CoV-2 transmissibility proportion of household contact who will become positive for SARS-COV2 using PCR 14 days
See also
  Status Clinical Trial Phase
Completed NCT04369456 - Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients N/A
Completed NCT04527471 - Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 Phase 2
Recruiting NCT04410510 - P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 Phase 2/Phase 3
Withdrawn NCT04383899 - Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019
Completed NCT04542915 - COVID-19-Related Health and Practices Among Dental Hygienists
Not yet recruiting NCT04400019 - Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM) Phase 2/Phase 3
Terminated NCT04954014 - Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients Phase 2
Completed NCT04532632 - Taste and Smell Impairment in Critically Ill COVID-19 Patients
Suspended NCT04385771 - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation N/A
Terminated NCT04530448 - Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization Phase 4
Completed NCT04413435 - Clinical Characteristics of Critically Ill Patients With COVID-19
Terminated NCT05593770 - International Sites: Novel Experimental COVID-19 Therapies Affecting Host Response Phase 2/Phase 3
Completed NCT04510493 - Canakinumab in Patients With COVID-19 and Type 2 Diabetes Phase 3
Active, not recruiting NCT04587219 - The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older Phase 2
Withdrawn NCT05430958 - Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers Phase 1
Completed NCT04596579 - SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida
Completed NCT04405934 - COG-UK Project Hospital-Onset COVID-19 Infections Study N/A
Enrolling by invitation NCT04484025 - SPI-1005 Treatment in Moderate COVID-19 Patients Phase 2
Terminated NCT04442230 - NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) Phase 2
Terminated NCT04642638 - Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure Phase 2/Phase 3